FLIR Stock Falls, Admits 'Decelerating' Demand For Temperature Screening
By Joey Walter, Published Aug 07, 2020, 09:46am EDT
Is the boom going to bust for temperature screening? FLIR disappointed investors with their Q2 results acknowledging decelerating demand for temperature screening.
In this report, we examine why FLIR is already on the downswing of its Elevated Skin Temperature (EST) boom and why customers are delaying and calling off their orders.
These delays have caused FLIR to withdraw a previously issued financial guidance for the remainder of 2020, meant to be announced with these results, signaling their postponed bookings to the end of 2020 and uncertainty going forward for investors.